Skip to main content

DeFi Development Corp. Chief Strategy Officer to Speak at 21st Annual Needham Technology, Media, & Consumer Conference

BOCA RATON, FL, May 05, 2026 (GLOBE NEWSWIRE) — DeFi Development Corp. (Nasdaq: DFDV) (the “Company”), the first US public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced that Chief Strategy Officer Daniel Kang will be speaking at the 21st Annual Needham Technology, Media, & Consumer Conference on Tuesday, May 12, 2026, at 3:45 p.m. Eastern Time. A live webcast and replay of the session will be available on the Company’s Investor Relations website at https://defidevcorp.com/investor?tab=media-events. To register for the webcast, visit here: Registration Link. For more information, visit defidevcorp.com. To stay up to date with the latest developments and insights, subscribe to our blog. About DeFi Development Corp.DeFi Development Corp. (Nasdaq: DFDV) has adopted a treasury...

Continue reading

SS Innovations Surpasses 10,500 Surgeries Performed with the SSi Mantra Surgical Robotic System

FORT LAUDERDALE, Fla., May 05, 2026 (GLOBE NEWSWIRE) — SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that more than 10,500 cumulative surgeries have been successfully performed with the Company’s SSi Mantra surgical robotic system (the “SSi Mantra”). As of April 30, 2026, the cumulative number of multi-specialty procedures completed with the SSi Mantra exceeded 10,500, including more than 500 cardiac procedures, 170 telesurgeries, and 125 pediatric surgeries. Additionally, approximately 2,100 physicians have been trained on the SSi Mantra, which has been utilized to perform over 170 different types of procedures. Dr. Sudhir Srivastava,...

Continue reading

Nightfood Holdings Inc. (OTCQB: NGTF) Positioned at Center of Real-World Deployment of AI-Enabled Robotics Platform

NEW YORK, May 05, 2026 (GLOBE NEWSWIRE) — via AINewsWire — Nightfood Holdings inc. (OTCQB: NGTF) today announces its placement in an editorial published by AINewsWire (“AINW”), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. To view the full publication, “Service Robotics Growth Accelerates as Global Demand Fuels Strategic Expansion,” please visit: https://ibn.fm/7HGNd Global demand for service robotics is accelerating as industries increasingly turn to automation to address labor shortages, rising costs and operational inefficiencies. According to the International Federation of Robotics, service robot adoption continues to expand worldwide,...

Continue reading

HomeTrust Named to 2026 KBW Bank Honor Roll and Forbes’ 2026 List of America’s Best Banks

ASHEVILLE, N.C., May 05, 2026 (GLOBE NEWSWIRE) — HomeTrust Bancshares, Inc. (NYSE: HTB) (the “Company”), the holding company of HomeTrust Bank (“HomeTrust” or the “Bank”), announced it has been named to the 2026 KBW Bank Honor Roll for the second consecutive year. Only 6% of eligible banks were selected—representing 17 financial institutions—based on best-in-class earnings growth over the past 10 years. The Bank was also recently recognized on Forbes’ 2026 list of America’s Best Banks, which ranks the top 100 banks based on key metrics measuring growth, credit quality, profitability and stock performance. This is the third consecutive year HomeTrust has been recognized on the list. In addition, HomeTrust earned a spot on American Banker’s Best Banks to Work For for the second straight year and was recognized as a Best Place to Work...

Continue reading

InterDigital to Present at Four Upcoming Investor Conferences

WILMINGTON, Del., May 05, 2026 (GLOBE NEWSWIRE) — InterDigital, Inc. (Nasdaq: IDCC), a wireless, video and AI technology research and development company, today announced that the company will be presenting at four upcoming investor conferences:21st Annual Needham Technology, Media & Consumer Conference on May 12th, 2026, at 4:30 PM ET. J.P. Morgan 2026 Global Technology, Media and Communications Conference on May 18th, 2026 at 4:10 PM ET. Evercore Global TMT Conference on June 2nd, 2026, at 10:55 AM ET. William Blair 46th Annual Growth Stock Conference on June 2nd, 2026, at 11:00 AM ET.These events will be webcast live and an archived replay of the presentations will also be available following the conferences. For more information, please visit the Investors section of the company’s website closer to the event. About...

Continue reading

Achieve Life Sciences to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 12, 2026

SEATTLE and VANCOUVER, British Columbia, May 05, 2026 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence, today announced it will report its first quarter 2026 financial results and provide a corporate update on Tuesday, May 12, 2026, at 8:30 AM EDT. To access the webcast, please use the following link: 1Q26 Earnings Webcast. Alternatively, you may access the live conference call by dialing 877-269-7756 (U.S. & Canada) or +1 201-689-7817 (International) and referencing conference ID 13759781. A webcast replay will be available approximately three hours after the call and archived on the website for 90 days. About Achieve Life Sciences, Inc.Achieve Life Sciences,...

Continue reading

Eagle Nuclear Energy Announces Commencement of Environmental Baseline Studies in Advance of PFS-Related Drill Program at Aurora

Numerous consultants engaged to commence a multi-faceted environmental baseline studies program in advance of the PFS-related drill program at Aurora RENO, Nev., May 05, 2026 (GLOBE NEWSWIRE) — Eagle Nuclear Energy Corp. (“Eagle” or the “Company”) (NASDAQ: NUCL), a next-generation nuclear energy company that owns the largest conventional, measured and indicated uranium deposit in the United States, today announced that it has launched a comprehensive environmental baseline studies campaign prior to the commencement of the previously announced 27,000 ft Pre-Feasibility Study (“PFS”) related drill program at its flagship Aurora Uranium Project (“Aurora” or the “Project”) site located along the Oregon–Nevada border. Eagle’s VP of Operations, Vishal Gupta, stated, “Initiating environmental baseline studies marks an important milestone...

Continue reading

Sofwave Medical Reports First Quarter Fiscal 2026 Financial Results and Business Highlights

First quarter revenue of $24.4M, +46% year-over-year growth; IFRS gross margin of 75.0% First quarter usage fee revenue of $11.0M, +56% year-over-year growthIFRS and non-IFRS net income of $1.3M and $1.7M versus IFRS and non-IFRS net losses of $1.1M and $0.4M in the prior year ago periodApproximately 2,900 Sofwave systems sold to date and more than 865,000 Sofwave treatments administered since commercializationSAN CLEMENTE, Calif., May 05, 2026 (GLOBE NEWSWIRE) —  Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, reported financial results for the three-month period ended March 31, 2026, and recent business highlights. First Quarter 2026 Financial HighlightsFirst Quarter 2026 Revenue of $24.4M; representing 46% year-over-year growthRecurring...

Continue reading

Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update

Completed enrollment of the Phase 3 APOLLO study of bitopertin in erythropoietic protoporphyria (EPP); topline data expected in Q4 2026Updated data from Phase 2 study of DISC-0974 in patients with anemia of myelofibrosis (MF) to be shared at the American Society of Clinical Oncology (ASCO) Annual Meeting as an oral presentationProgressing ongoing Phase 2 study of DISC-3405 in polycythemia vera (PV) and Phase 1b study of DISC-3405 in sickle cell disease (SCD), with data from both studies expected in Q4 2026Strong financial position ending Q1 with approximately $730 million in cash, cash equivalents, and marketable securities, providing runway into 2029WATERTOWN, Mass., May 05, 2026 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization...

Continue reading

IPG Photonics Announces First Quarter 2026 Financial Results

 Strong Start to the Year on Growing Demand and Continued Focus on Execution of Strategic Initiatives Managing Costs and Mitigating Tariff Impact on Gross Margin MARLBOROUGH, Mass., May 05, 2026 (GLOBE NEWSWIRE) — IPG Photonics Corporation (NASDAQ: IPGP) today reported financial results for the first quarter ended March 31, 2026.    Three Months Ended March 31,(In millions, except per share data and percentages)     2026       2025     ChangeRevenue   $ 265.5     $ 227.8     17 %Gross margin     37.5 %     39.4 %    Operating income (loss)   $ (7.7 )   $ 1.8     NMOperating margin   (2.9)%     0.8 %    Net income   $ 1.6     $ 3.8     (58)%Earnings per diluted share   $ 0.04     $ 0.09     (56)%Non-GAAP Measures*            Adjusted gross margin     37.8 %     40.0 %    Adjusted EBITDA   $ 35.2     $ 32.7     8 %Adjusted...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.